MarketLens
Sign Up

Eli Lilly Just Made History. Here's What It Means for Your Portfolio

11 months ago
SHARE THIS ON:

2025112502.jpg

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•3 weeks ago

Could Eli Lilly's Newest Weight Loss Strategy Pay Off for Decades?

Eli Lilly is expanding global access to its weight loss and diabetes drugs, targeting low-income countries where disease prevalence is high. The move could unlock a large, long-duration market opportu...
Stock News•1 months ago

Eli Lilly Just Won FDA Approval for a Once Weekly Insulin and the Stock Is Knocking on $1,200

Eli Lilly won FDA approval for a once-weekly insulin, with the stock up 60% and nearing $1,200. The debate is whether the new diabetes product meaningfully adds to a stock already at record highs.
Stock News•2 months ago

GLP-1's Drove Eli Lilly's Record-Breaking Q2, but AI Will Be Its Future

Eli Lilly's record-breaking Q2 was driven by GLP-1 drugs, but AI is expected to shape its future. The market's focus on GLP-1s may shift as AI becomes a key growth driver.

Breaking News

View All →

Top Headlines

View More →
Stock News•59 minutes ago

Jim Cramer sees major implications from SK Hynix's home-run quarter

Stock News•1 hour ago

Google parent Alphabet tumbles after profit disappoints, warns AI is battering its cash flow

Stock News•1 hour ago

Jim Cramer says these tech giants can weather market turbulence

Stock News•1 hour ago

Alphabet Inc. (GOOG) Misses Q3 Earnings and Revenue Estimates

Stock News•1 hour ago

Alphabet (GOOGL) Q3 Earnings and Revenues Miss Estimates